Treatment outcome of creatine transporter deficiency: international retrospective cohort study.

Metab Brain Dis 2018 06 12;33(3):875-884. Epub 2018 Feb 12.

Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

To evaluate the outcome of current treatment for creatine transporter (CRTR) deficiency, we developed a clinical severity score and initiated an international treatment registry. An online questionnaire was completed by physicians following patients with CRTR deficiency on a treatment, including creatine and/or arginine, and/or glycine. Clinical severity score included 1) global developmental delay/intellectual disability; 2) seizures; 3) behavioural disorder. Phenotype scored 1-3 = mild; 4-6 = moderate; and 7-9 = severe. We applied the clinical severity score pre- and on-treatment. Seventeen patients, 14 males and 3 females, from 16 families were included. Four patients had severe, 6 patients had moderate, and 7 patients had a mild phenotype. The phenotype ranged from mild to severe in patients diagnosed at or before 2 years of age or older than 6 years of age. The phenotype ranged from mild to severe in patients with mildly elevated urine creatine to creatinine ratio. Fourteen patients were on the combined creatine, arginine and glycine therapy. On the combined treatment with creatine, arginine and glycine, none of the males showed either deterioration or improvements in their clinical severity score, whereas two females showed improvements in the clinical severity score. Creatine monotherapy resulted in deterioration of the clinical severity score in one male. There seems to be no correlation between phenotype and degree of elevation in urine creatine to creatinine ratio, genotype, or age at diagnosis. Combined creatine, arginine and glycine therapy might have stopped disease progression in males and improved phenotype in females.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11011-018-0197-3DOI Listing
June 2018
13 Reads
2.640 Impact Factor

Publication Analysis

Top Keywords

clinical severity
24
severity score
24
severe patients
12
arginine glycine
12
creatine arginine
12
creatine
9
combined creatine
8
improvements clinical
8
glycine therapy
8
crtr deficiency
8
treatment creatine
8
ranged mild
8
mild severe
8
creatine transporter
8
patients
8
phenotype ranged
8
urine creatine
8
creatine creatinine
8
creatinine ratio
8
clinical
6

References

(Supplied by CrossRef)

OT Betsalel et al.
Mol Genet Metab 2012

KM Cecil et al.
Ann Neurol 2001

A Chilosi et al.
Neurocase 2008

C Fons et al.
J Inherit Metab Dis 2008

P Garcia et al.
Pediatr Neurol 2012

T Kleefstra et al.
Clin Genet 2005

R Malheiro et al.
Acta Medica Port 2012

S Mercimek-Mahmutoglu et al.
Mol Genet Metab 2010

GS Salomons et al.
Am J Hum Genet 2001

A Sempere et al.
J Inherit Metab Dis 2009

Similar Publications